Omicron’s message on vaccines: Boosting begets breadth
Cell. 2022 Feb 3;185(3):411-413. doi: 10.1016/j.cell.2022.01.006. Epub 2022 Jan 14. ABSTRACT In this issue of Cell, three studies confirm that SARS-CoV-2 Omicron strongly evades a
Cell. 2022 Feb 3;185(3):411-413. doi: 10.1016/j.cell.2022.01.006. Epub 2022 Jan 14. ABSTRACT In this issue of Cell, three studies confirm that SARS-CoV-2 Omicron strongly evades a
Science. 2021 Dec 10;374(6573):1353-1360. doi: 10.1126/science.abl9463. Epub 2021 Oct 26. ABSTRACT The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outcompeted previously
bioRxiv. 2021 Aug 17:2021.08.17.456689. doi: 10.1101/2021.08.17.456689. Preprint. ABSTRACT The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outcompeted previously prevalent variants and
Cell. 2021 Sep 16;184(19):4969-4980.e15. doi: 10.1016/j.cell.2021.07.025. Epub 2021 Jul 23. ABSTRACT Memory B cell reserves can generate protective antibodies against repeated SARS-CoV-2 infections, but with
medRxiv. 2021 Jul 13:2021.07.09.21260221. doi: 10.1101/2021.07.09.21260221. Preprint. ABSTRACT Genomic regions have been associated with COVID-19 susceptibility and outcomes, including the chr12q24.13 locus encoding antiviral proteins
Science. 2021 Aug 6;373(6555):642-648. doi: 10.1126/science.abi9745. Epub 2021 Jun 24. ABSTRACT Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the
bioRxiv. 2021 Apr 14:2021.04.13.439709. doi: 10.1101/2021.04.13.439709. Preprint. ABSTRACT Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains
bioRxiv. 2021 Mar 10:2021.03.10.434840. doi: 10.1101/2021.03.10.434840. Preprint. ABSTRACT Memory B cell reserves can generate protective antibodies against repeated SARS-CoV-2 infections, but with an unknown reach
JCI Insight. 2021 Jan 11;6(1):e143129. doi: 10.1172/jci.insight.143129. ABSTRACT The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), coupled with a lack of therapeutics,
Cell. 2020 Dec 10;183(6):1496-1507.e16. doi: 10.1016/j.cell.2020.10.051. Epub 2020 Nov 3. ABSTRACT Antibodies are key immune effectors that confer protection against pathogenic threats. The nature and